ロード中...
National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys
BACKGROUND: Recent pilot trials have demonstrated the safety of transplanting HCV-viremic kidneys into HCV-seronegative recipients. However, it remains unclear if allograft function is impacted by donor HCV-viremia or recipient HCV-serostatus. METHODS: We used national United States registry data to...
保存先:
| 出版年: | J Am Soc Nephrol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Nephrology
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779360/ https://ncbi.nlm.nih.gov/pubmed/31515244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2019050462 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|